4Poch E,Giner V,Nunez DG,et al.Association of the Gproteinβ3 sub-unitT allete with insulin resistance in essential hypertension[J].Clin Exper Hy-pertension.2002,24(5):345-353.
5Horikawa Y,Oda N,Cox NJ,et al.Genetic variation in the gene encoding calpain 10 is associatedwithtype2diabetesmellitus[J].Nat Gent,2000,26(2):163-171.
6UK prospective Diabetes Study groupl Tight blood pressure and risk ofmacrovascular and micro vascular complications in typediabetes;UKPDS38[J].BMJ,1998,317:703-713.
7Hanssonl,ZanchettA,Carruthers,et al.For the HOT atudy group;Effects of intersive blood pressure lowering and lowdoes aspirin inpatimal Treatment (HOT) randomized trial[J].Lancet,1998,351:1755-1762.
8ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group1Major outcomes in high-risk hypertensive patients randomized to angiotensin-convarting enzyme inhibitor or calcium channel-blocker vs diuretic.The Antihypertensive and Lipid-Lowering Treatmentto Prevent Heart Attack Trial (ALLHAT)[J].JAMA,2002.288(23):2981-2997.
9Schafers RF.Diuretic therapy of hypertension with Typediabetes,rational therapy or malpractice[J].Ther Umsch,2000,57(6):368-373.
10Kovoor P.Yung A,Byth K.et al.Comparison of the long-term efficacy of implantable defibrillators and sotalol for documented spontaneous sus-tained ventricular tachyarrhythmias secondary to coronary artery disease[J].Aust NZJ Med,1999,29(3):331-341.
